In contrast to previous findings [18], MARCH2 RNA levels in all cell types we tested (H9, THP-1, primary CD4+ T cells and MDMs) were unaffected by HIV-1 infection and IFN-β treatment. This evidence concerns the gene MARCHF2 and HIV-1 infection.